What's the problem? [Regulatives / Guidelines]

posted by DavidManteigas – Portugal, 2017-05-17 13:25 (2497 d 20:49 ago) – Posting: # 17366
Views: 21,993

Thank you all for your feedbacks.

It would be interesting to study the within study variation for the same compound in the same unit to understand which is the main source of variability. Although I understand the point of El Maestro about assay sensitivity, I don't think that could be pointed as a cause for a study which presented high variability when other studies reported low variability. I understand the approach to highly variable drugs, when the drug is actually highly variable per se and not due to study conduct or assay sensibility.

Complete thread:

UA Flag
Activity
 Admin contact
22,940 posts in 4,812 threads, 1,639 registered users;
45 visitors (0 registered, 45 guests [including 6 identified bots]).
Forum time: 09:15 CET (Europe/Vienna)

Those people who think they know everything
are a great annoyance to those of us who do.    Isaac Asimov

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5